Method and test kits for identifying Alzheimer's disease by testing cerebrospinal fluid
US5486460A · kind A · utility
6Cited by
2References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 20, 1993 |
| Grant date | Jan 23, 1996 |
| Priority date | — |
| Expiry date | May 20, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/811
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method for aid in diagnosing Alzheimer's disease in patients exhibiting the Alzheimer's characteristic dementia is described. Cerebrospinal fluid (CSF) suspected of containing amyloid particles is removed from a patient, living or deceased, concentrated and then stained to determine a count of such particles per unit volume. The method provides a means for confirming Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.